Jorge Conde

Jorge Conde is the current Director at Octant. Jorge was previously the CEO at IDRx and Vicinitas Therapeutics. Jorge has also worked as the Chief Business Officer at Dyno Therapeutics and EQRx. Prior to that, they were a Principal at Komodo Health and Asimov. Jorge has also worked at Octant and Tmunity Therapeutics Incorporated as an Associate. Jorge began their career as an analyst at Andreessen Horowitz.

Jorge Conde has a Master of Business Administration from Harvard Business School, a Master of Science in the Biomedical Enterprise Program from the Massachusetts Institute of Technology, and a Bachelor of Arts in Biology from The Johns Hopkins University.